Paclitaxel IMpurity O
|
|
Paclitaxel IMpurity O Eigenschaften
- Schmelzpunkt:
- 149-150 °C
- Siedepunkt:
- 982.1±65.0 °C(Predicted)
- Dichte
- 1.38±0.1 g/cm3(Predicted)
- pka
- 11.91±0.20(Predicted)
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Bildanzeige (GHS) | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alarmwort | Achtung | |||||||||||||||||||||||||||||||||||
Gefahrenhinweise |
|
|||||||||||||||||||||||||||||||||||
Sicherheit |
|
Paclitaxel IMpurity O Chemische Eigenschaften,Einsatz,Produktion Methoden
Paclitaxel IMpurity O Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Paclitaxel IMpurity O Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 44)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Standardpharm Co. Ltd. | 86-714-3992388 |
overseasales1@yongstandards.com | United States | 14332 | 58 |
China National Standard Pharmaceutical Corporation Limited | +8615391658522 |
overseasales@yongstandards.com | China | 11922 | 58 |
Moxin Chemicals | +8617320513646 |
mike@molcoo.com | China | 9511 | 58 |
Guangzhou PI PI Biotech Inc | 020-81716320 +86-13602409664 |
Sales@pipitech.com | China | 3633 | 55 |
ChemCell Biomedicine Co.,Ltd. | 020-13556033878 2965585218 13556033878 |
chemcell@hotmail.com | China | 369 | 52 |
BOC Sciences | 1-631-485-4226; 16314854226 |
info@bocsci.com | United States | 14055 | 65 |
ChemStrong Scientific Co.,Ltd | 0755-0755-66853366 13670046396 |
sales@chem-strong.com | China | 18070 | 56 |
Sichuan Wei Keqi Biological Technology Co., Ltd. | 028-81700200 18116577057 |
3003855609@qq.com | China | 7787 | 56 |
BOC Sciences | 16314854226 |
info@bocsci.com | United States | 9923 | 65 |
Shanghai Yihe Biological Technology Co., Ltd. | 17721395025 |
2423903095@qq.com | China | 4094 | 58 |
- Paclitaxel IMpurity O
- N-Cinnamoyl N-Debenzoyl Paclitaxel
- Paclitaxel EP Impurity O
- Paclitaxel impurity 14/Paclitaxel EP Impurity O/N-Cinnamoyl-N-debenzoylpaclitaxel/(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-9-(((2R,3S)-3-cinnamamido-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-3,4,4a,5,6,9,10,1
- Paclitaxel EP Impurity O N-cinnamoyl-N-debenzoylpaclitaxel
- Paclitaxel Impurity 15(Paclitaxel EP Impurity O)
- Benzenepropanoic acid, α-hydroxy-β-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester,...
- N-Debenzoyl-N-cinnamoylpaclitaxel
- 4,10β-bis(acetyloxy)-1,7β-dihydroxy-13α-[[(2R,3S)-2-hydroxy-3-phenyl-3-(2-phenylacetamido)propanoyl]oxy]-9-oxo-5β,20-epoxytax-11-en-2α-ylbenzoate(N-debenzoyl-N-(phenylacetyl)paclitaxel)
- (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-9-(((2R,3S)-3-cinnamamido-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate
- (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-9-(((2R,3S)-3-cinnamamido-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro
- 219783-77-4